Selenious Acid Injection, USP 12 mcg/2 mL (6 mcg/2mL), For intravenous use, packaged in a) 2mL Si...

FDA Drug Recall #D-0798-2026 - Class II, July 24, 2026

Recall Summary

Recall Number D-0798-2026
Classification Class II - Moderate risk
Date Initiated July 24, 2026
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm American Regent, Inc.
Location Shirley, NY
Product Type Drugs
Quantity 41,680 vials

Product Description

Selenious Acid Injection, USP 12 mcg/2 mL (6 mcg/2mL), For intravenous use, packaged in a) 2mL Single-Dose Vial (NDC 0517-6502-01), and b)10x2mL Single-Dose Vial (NDC 0517-6502-10), Rx Only, AMERICAN REGENT, INC., SHIRLEY, NY 11967.

Reason for Recall

Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde

Distribution Pattern

Nationwide within the U.S

Lot / Code Information

Lot #: 25090, Exp. Date 2/28/2027.

Other Recalls from American Regent, Inc.

Recall # Classification Product Date
D-0799-2026 Class II Multrys (Trace Elements Injection 4, USP), For ... Jul 24, 2026
D-0793-2026 Class II Cyanocobalamin injection USP, 10,000 mcg/10 mL ... Jul 24, 2026
D-0796-2026 Class II ACETYLCYSTEINE SOLUTION, USP, 10% (100 mg/mL), ... Jul 24, 2026
D-0801-2026 Class II Tralement (trace elements injection 4*, USP), p... Jul 24, 2026
D-0800-2026 Class I Papaverine HCl Injection, USP, 60 mg/2 mL (30 m... Jul 24, 2026

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections, all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications, even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications, use a drug take-back program.